The NeXtStep in SPR based fragment screening

6^th International Conference and Exhibition on Biosensors & Bioelectronics

September 22-23, 2016 Phoenix, USA

Eric L Reese

SensiQ Technologies Inc., USA

Posters & Accepted Abstracts: J Biosens Bioelectron

Abstract :

SensiQâ�?�?s patented gradient injection methods provide KDâ�?�?s from single injections, allowing SensiQ instruments to eliminate secondary screens such as one competitorâ�?�?s â�?�?Affinity Screenâ�?. No other SPR providers have gradient injection technology. SensiQ Pioneer FE customers have demonstrated that a combination of excellent sensitivity, OneStep�?® gradient injections and the integrated Active Selection software provides superior results over other SPR suppliers. Now SensiQ has developed a new binding competition assay method for rapidly screening fragments, NeXtStep. Like OneStep�?®, NeXtStep enables full kinetic analysis in single competition injection and competition is clearly seen as a lack of binding in the presence of the competitor. Taken together, OneStep�?® and NeXtStep enable straight forward fragment screening workflow optimization and thus a faster drug discovery process.

Biography :

Email: eric.reese@sensiqtech.com